bioRxiv Science⌕ Search

bioRxiv · 10.1101/2023.05.12.540435

Coordinated Chemokine Expression Defines Macrophage Subsets Across Tissues

Abstract

Tissue-resident macrophages in the lung comprising alveolar and interstitial macrophages (IMs) display a high degree of heterogeneity. In general, macrophage heterogeneity is thought to arise from various forms of activation that are heavily confounded by the recruitment of monocytes to the tissue-resident macrophage pool. To better understand the functional heterogeneity of IMs in the lung, we profiled the transcription of resident CD206hi and CD206lo IMs under steady-state and inflammatory conditions, excluding recruited macrophages. Rather than observing conventional in vitro M1 and M2 activation states, we identified seven chemokine-expressing IM subsets: IMck1 (Ccl2, Ccl7, Ccl12, and some Cxcl14), IMck2-4 (Ccl3, Ccl4, Ccl5, Cxcl1, Cxcl2, and Cxcl3), IMck5 (Ccl8), IMck6 (Ccl6 and Ccl9), IMck7 (Cxcl9 and Cxcl10), IMck8 (Cxcl13), and IMck9 (Ccl24), which were found in steady-state or induced by acute inflammation. Beyond the mouse lung, similar coordinated chemokine signatures were observed in macrophages and monocytes from other tissues and across species. Although all IMs expressed Pf4 (CXCL4), mainly CD206hi IMs were selectively depleted in Pf4CreR26EYFP-DTR mice. Loss of CD206hi IMs resulted in significantly reduced inflammatory cell influx in allergen- and infection-driven models, as well as significantly diminished tertiary lymphoid formation and subsequent accumulation of GL7+ germinal center B cells. Overall, our study highlights a division of labor among interstitial macrophages, reflected by the coordinated production of chemokines to control inflammatory cell influx and organize tertiary lymphoid tissue architecture. One Sentence SummaryThe study highlights a division of labor among interstitial macrophages, reflected by the coordinated production of chemokines to control inflammatory cell influx and organize tertiary lymphoid tissue architecture.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Li, X., Mara, A. B., Musial, S., Rawat, K., King, W. T., Kolling, F. W., Gerebtsov, N., Jakubzick, C. V.. 2023-05-14. Coordinated Chemokine Expression Defines Macrophage Subsets Across Tissues. https://doi.org/10.1101/2023.05.12.540435

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Ksp37 is a rapidly mobilized NK cell secretory protein that engages FGF2

A key feature of natural killer (NK) cells is their preloaded arsenal of effector molecules, allowing them to rapidly respond upon activation. In this study, we characterized a previously unexplored secretory protein, termed killer-specific secretory protein of 37 kDa (Ksp37), which is highly abundant in differentiated CD56dim NK cells. Ksp37 is rapidly secreted in a dose-dependent and JAK-1 dependent manner upon low levels of cytokine stimulation, making it a sensitive readout for NK cell activation. Following secretion, intracellular levels were rapidly replenished, preserving responsiveness to subsequent cytokine stimulation. We found that Ksp37 is stored in polarized intracellular compartments distinct from those containing canonical cytotoxic effector molecules, including granzyme B and perforin, which require stronger stimulation for release. Lastly, we identified Ksp37 as a novel binding partner of fibroblast growth factor 2 (FGF2). This opens new avenues of exploration for the role of NK cells in remodeling their extracellular environment by modulating the FGF2-FGFR1 axis, which plays a key role in tumor growth, angiogenesis and tissue repair.

immunology↗

ACE-engineered human iPSC-derived neutrophils enhance host defense against multidrug-resistant bacterial infections

Severe neutropenia predisposes patients to life-threatening infections, while donor-dependent granulocyte transfusions are limited by availability and variable cell quality. Here, we engineered human induced pluripotent stem cells (iPSCs) to constitutively or inducibly express angiotensin-converting enzyme (ACE) and differentiated them into functional ACE-engineered neutrophils (ACE-iNeu). ACE expression enhanced granulocytic maturation, reactive oxygen species generation, inflammatory cytokine production, and antimicrobial signaling. ACE-iNeu exhibited enhanced bactericidal activity against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. Following adoptive transfer into neutropenic mice, ACE-iNeu significantly reduced circulating and tissue bacterial burdens. Integrated metabolomic and transcriptomic analyses revealed ACE-associated alterations in adenine nucleotide abundance and developmental and inflammatory pathways. Together, these findings establish ACE engineering as a strategy to enhance the production and antimicrobial function of human iPSC-derived neutrophils and support further preclinical development of engineered granulocyte therapies for severe drug-resistant infections.

immunology↗

Tetravalent dengue mRNA vaccination orchestrates balanced four-serotype immunity with durable memory and protection in mice.

An effective dengue vaccine must establish durable immunity across four dengue virus (DENV) serotypes, evade antibody-dependent enhancement (ADE), and overcome immune imprinting from prior exposure. Here, we developed TetprM-E mRNA-LNP, a tetravalent vaccine comprising LNP-formulated nucleoside-modified mRNAs encoding DENV1-4 precursor membrane-envelope (prM-E) antigens, and evaluated its immunogenicity, durability, protection and breath across serotype-specific immune backgrounds. Three immunization strategies elicited neutralizing titers greater than 1:1500 against each serotype. Passive transfer of immune sera conferred 100% survival and reduced viremia after lethal DENV2 challenge in immunocompromised mice. Vaccination induced DENV envelope (env)-specific CD8+T cells and CD4-dependent germinal-center responses. DENV env-binding antibodies persisted for 34 weeks alongside DENV env-specific memory B cells. Vaccine-elicited sera showed no measurable in vitro ADE. Although monovalent priming initially biased antibody responses, TetprM-E mRNA-LNP vaccination broadened neutralization across DENV1-4 regardless of priming serotype. Together, TetprM-E mRNA-LNP elicits broad, durable, and protective immunity despite serologic constraints from pre-existing immunity.

immunology↗